 [2007-1-1]Cognitive and Adaptive Outcome in Low-Grade Pediatric Cerebellar Astrocytomas: Evidence of Diminished Cognitive and Adaptive Functioning in |
| [2007-1-1]Phase I Safety, Pharmacokinetic, and Pharmacodynamic Study of the Thrombospondin-1–Mimetic Angiogenesis Inhibitor ABT-510 in Patients With A |
| [2007-1-1]Optimizing Adjuvant Endocrine Therapy in Postmenopausal Women With Early-Stage Breast Cancer: A Decision Analysis |
| [2007-1-1]Assessing the Benefit of Radiation Therapy After Breast-Conserving Surgery for Ductal Carcinoma-In-Situ |
| [2007-1-1]Randomized Trial Comparing Cyclophosphamide, Epirubicin, and Fluorouracil With Cyclophosphamide, Methotrexate, and Fluorouracil in Premenopa |
| [2007-1-1]Fertility- and Menopause-Related Information Needs of Younger Women With a Diagnosis of Early Breast Cancer |
| [2007-1-1]Reliance on Hormone Receptor Assays of Surgical Specimens May Compromise Outcome in Patients With Breast Cancer |
| [2007-1-1]Switching to Anastrozole Versus Continued Tamoxifen Treatment of Early Breast Cancer: Preliminary Results of the Italian Tamoxifen Anastrozo |
| [2007-1-1]Effects of Exemestane Administered for 2 Years Versus Placebo on Bone Mineral Density, Bone Biomarkers, and Plasma Lipids in Patients With S |
| [2007-1-1]Objective Response to Chemotherapy As a Potential Surrogate End Point of Survival in Metastatic Breast Cancer Patients |
| [2007-1-1]Neoadjuvant Treatment of Postmenopausal Breast Cancer With Anastrozole, Tamoxifen, or Both in Combination: The Immediate Preoperative Anastr |
| [2007-1-1]Immunization With Mutant p53- and K-ras–Derived Peptides in Cancer Patients: Immune Response and Clinical Outcome |
| [2007-1-1]Evaluation of Randomized Discontinuation Design |
| [2007-1-1]Serum Proteomic Fingerprinting Discriminates Between Clinical Stages and Predicts Disease Progression in Melanoma Patients |
| [2007-1-1]Allogeneic Peripheral Blood Stem-Cell Compared With Bone Marrow Transplantation in the Management of Hematologic Malignancies: An Individual |
| [2007-1-1]Regression of Ocular Adnexal Lymphoma After Chlamydia Psittaci–Eradicating Antibiotic Therapy |
| [2007-1-1]Prognostic Value of Translocation t(11;18) in Tumoral Response of Low-Grade Gastric Lymphoma of Mucosa-Associated Lymphoid Tissue Type to Or |
| [2007-1-1]Hodgkin's Lymphoma in Elderly Patients: A Comprehensive Retrospective Analysis From the German Hodgkin's Study Group |
| [2007-1-1]Combination Antibody Therapy With Epratuzumab and Rituximab in Relapsed or Refractory Non-Hodgkin's Lymphoma |
| [2007-1-1]Report of an International Workshop to Standardize Baseline Evaluation and Response Criteria for Primary CNS Lymphoma |
| [2007-1-1]Introduction of Combined CHOP Plus Rituximab Therapy Dramatically Improved Outcome of Diffuse Large B-Cell Lymphoma in British Columbia |
| [2007-1-1]Improved Survival of Follicular Lymphoma Patients in the United States |
| [2007-1-1]Increased HER2 Gene Copy Number Is Associated With Response to Gefitinib Therapy in Epidermal Growth Factor Receptor–Positive Non–Small-Cell |
| [2007-1-1]Meta-Analysis of Postoperative Adjuvant Chemotherapy With Tegafur-Uracil in Non–Small-Cell Lung Cancer |
| [2007-1-1]Study of Paclitaxel, Etoposide, and Cisplatin Chemotherapy Combined With Twice-Daily Thoracic Radiotherapy for Patients With Limited-Stage S |
| [2007-1-1]Blood Pressure and Body Mass Index in Long-Term Survivors of Testicular Cancer |
| [2007-1-1]Identifying Patients at Risk for Significant Versus Clinically Insignificant Postoperative Prostate-Specific Antigen Failure |
| [2007-1-1]Adjuvant Cisplatin Plus Methotrexate Versus Methotrexate, Vinblastine, Epirubicin, and Cisplatin in Locally Advanced Bladder Cancer: Results |
| [2007-1-1]Use of the Internet to Obtain Cancer Information Among Cancer Patients at an Urban County Hospital |
| [2007-1-1]Persistence of Restrictions in Quality of Life From the First to the Third Year After Diagnosis in Women With Breast Cancer |
| [2007-1-1]Variability and Sample Size Requirements of Quality-of-Life Measures: A Randomized Study of Three Major Questionnaires |
| [2007-1-1]Predictive Value of Bone Resorption and Formation Markers in Cancer Patients With Bone Metastases Receiving the Bisphosphonate Zoledronic Ac |
| [2007-1-1]Effect of Individual Psychological Intervention in Chinese Women With Gynecologic Malignancy: A Randomized Controlled Trial |
| [2007-1-1]Distal cT2N0 Rectal Cancer: Is There an Alternative to Abdominoperineal Resection? |
| [2007-1-1]Phase II/III Study of Doxorubicin With Fluorouracil Compared With Streptozocin With Fluorouracil or Dacarbazine in the Treatment of Advanced |
| [2007-1-1]Phase I Trial of Systemic Oxaliplatin Combination Chemotherapy With Hepatic Arterial Infusion in Patients With Unresectable Liver Metastases |
| [2007-1-1]Hepatic Arterial Oxaliplatin Infusion Plus Intravenous Chemotherapy in Colorectal Cancer With Inoperable Hepatic Metastases: A Trial of the |
| [2007-1-1]Improved Hepatic Toxicity Profile of Portal Vein Adjuvant Hepatic Infusional Chemotherapy |
| [2007-1-1]Phase III Randomized Trial of FOLFIRI Versus FOLFOX4 in the Treatment of Advanced Colorectal Cancer: A Multicenter Study of the Gruppo Oncol |
| [2007-1-1]Phase III Study of Weekly High-Dose Infusional Fluorouracil Plus Folinic Acid With or Without Irinotecan in Patients With Metastatic Colorec |
| [2007-1-1]Raf: A Strategic Target for Therapeutic Development Against Cancer |
| [2007-1-1]Phase II Trial of Carcinoembryonic Antigen Radioimmunotherapy With 131I-Labetuzumab After Salvage Resection of Colorectal Metastases in the |
| [2007-1-1]Aneurysmal Bone Cyst: A Review of 150 Patients |
| [2007-1-1]Dacarbazine, Cisplatin, and Interferon-Alfa-2b With or Without Interleukin-2 in Metastatic Melanoma: A Randomized Phase III Trial (18951) of |
| [2007-1-1]Biology of Desmoplastic Melanoma: A Case-Control Comparison With Other Melanomas |
| [2007-1-1]Randomized Trial of Radiotherapy Versus Concurrent Chemoradiotherapy Followed by Adjuvant Chemotherapy in Patients With American Joint Commi |
| [2007-1-1]Phase I Trial of Recombinant Immunotoxin RFB4(dsFv)-PE38 (BL22) in Patients With B-Cell Malignancies |
| [2007-1-1]Psychoactive Medications and Risk of Delirium in Hospitalized Cancer Patients |
| [2007-1-1]Longitudinal Assessment of Hematopoietic Abnormalities After Autologous Hematopoietic Cell Transplantation for Lymphoma |
| [2007-1-1]Effect of Age and Previous Autologous Transplantation on Nonrelapse Mortality and Survival in Patients Treated With Reduced-Intensity Condit |
| [2007-1-1]Research-Design Issues in Cancer-Symptom–Management Trials Using Complementary and Alternative Medicine: Lessons From the National Cancer In |
| [2007-1-1]Randomized Phase IIB Trial of BLP25 Liposome Vaccine in Stage IIIB and IV Non–Small-Cell Lung Cancer |
| [2007-1-1]Phase I/IIa Study of Cisplatin and Gemcitabine As Induction Chemotherapy Followed by Concurrent Chemoradiotherapy With Gemcitabine and Pacli |
| [2007-1-1]Phase II Study of Erlotinib (OSI-774) in Patients With Advanced Hepatocellular Cancer |
| [2007-1-1]Phase I Trial of Tipifarnib in Patients With Recurrent Malignant Glioma Taking Enzyme-Inducing Antiepileptic Drugs: A North American Brain T |
| [2007-1-1]Racial Disparities in Treatment and Survival Among Women With Early-Stage Breast Cancer |
| [2007-1-1]Plasma Carotenoids and Recurrence-Free Survival in Women With a History of Breast Cancer |
| [2007-1-1]Explaining Differences in Attitude Toward Adjuvant Chemotherapy Between Experienced and Inexperienced Breast Cancer Patients |
| [2007-1-1]Use of a Case Definition Approach to Identify Cancer-Related Fatigue in Women Undergoing Adjuvant Therapy for Breast Cancer |
| [2007-1-1]Euthanasia and Depression: A Prospective Cohort Study Among Terminally Ill Cancer Patients |
| [2007-1-1]Fatigue in Long-Term Hodgkin's Disease Survivors: A Follow-Up Study |
| [2007-1-1]Patients' Perceptions of Quality of Care for Colorectal Cancer by Race, Ethnicity, and Language |
| [2007-1-1]Quantitative Methylation-Specific Polymerase Chain Reaction Gene Patterns in Urine Sediment Distinguish Prostate Cancer Patients From Contro |
| [2007-1-1]Risk-Adapted Androgen Deprivation and Escalated Three-Dimensional Conformal Radiotherapy for Prostate Cancer: Does Radiation Dose Influence |
| [2007-1-1]Prostate-Specific Antigen Nadir and Cancer-Specific Mortality Following Hormonal Therapy for Prostate-Specific Antigen Failure |
| [2007-1-1]Combination of Paclitaxel, Ifosfamide, and Cisplatin Is an Effective Second-Line Therapy for Patients With Relapsed Testicular Germ Cell Tum |
| [2007-1-1]Lack of Efficacy of Two Consecutive Treatments of Radioimmunotherapy With 131I-cG250 in Patients With Metastasized Clear Cell Renal Cell Car |
| [2007-1-1]Lymphovascular Invasion Is Independently Associated With Overall Survival, Cause-Specific Survival, and Local and Distant Recurrence in Pati |
| [2007-1-1]Use of Molecular Tumor Characteristics to Prioritize Mismatch Repair Gene Testing in Early-Onset Colorectal Cancer |
| [2007-1-1]Peer-Delivered Smoking Counseling for Childhood Cancer Survivors Increases Rate of Cessation: The Partnership for Health Study |
| [2007-1-1]Minority Adult Survivors of Childhood Cancer: A Comparison of Long-Term Outcomes, Health Care Utilization, and Health-Related Behaviors From |
| [2007-1-1]Stroke As a Late Treatment Effect of Hodgkin's Disease: A Report From the Childhood Cancer Survivor Study |
| [2007-1-1]No Advantage of Dexamethasone Over Prednisolone for the Outcome of Standard- and Intermediate-Risk Childhood Acute Lymphoblastic Leukemia in |
| [2007-1-1]Low-Dose Chemotherapy for Epstein-Barr Virus–Positive Post-Transplantation Lymphoproliferative Disease in Children After Solid Organ Transpl |
| [2007-1-1]Favorable Prognosis for Patients 12 to 18 Months of Age With Stage 4 Nonamplified MYCN Neuroblastoma: A Children's Cancer Group Study |
| [2007-1-1]Hyperdiploidy Plus Nonamplified MYCN Confers a Favorable Prognosis in Children 12 to 18 Months Old With Disseminated Neuroblastoma: A Pediat |
| [2007-1-1]Evidence for an Age Cutoff Greater Than 365 Days for Neuroblastoma Risk Group Stratification in the Children's Oncology Group |
| [2007-1-1]Late Side Effects of Short-Course Preoperative Radiotherapy Combined With Total Mesorectal Excision for Rectal Cancer: Increased Bowel Dysfu |
| [2007-1-1]Salvage Therapy of Progressive and Recurrent Hodgkin’s Disease: Results From a Multicenter Study of the Pediatric DAL/GPOH-HD Study Group |
| [2007-1-1]Deletions Affecting Codons 557-558 of the c-KIT Gene Indicate a Poor Prognosis in Patients With Completely Resected Gastrointestinal Stromal |
